Welcome to the UPF Digital Repository
Browsing by Author "Conde Estévez, David"
- Home
- →
- Browsing by Author
JavaScript is disabled for your browser. Some features of this site may not work without it.
Browsing by Author "Conde Estévez, David"
Now showing items 1-11 of 11
-
Albert-Marí, Asunción; Jiménez-Pulido, Inmaculada; San José-Ruiz, Begoña; Conde Estévez, David; Gil-Lemus, Mª Ángeles; Cercós-Lletí, Ana Cristina; Esteban-Mensua, M. Jesús; Díaz-Carrasco, Mª Sacramento (SAGE Publications, 2022)
-
Clasificación del daño tisular de antineoplásicos: Consenso del Grupo Español de Farmacia OncológicaAlbert-Marí, Asunción; Gil-Lemus, Mª Ángeles; Conde Estévez, David; José-Ruiz, Begoña San; Jiménez-Pulido, Inmaculada; Jiménez-Pulido, Mª Jesús; Cercós-Lletí, Ana Cristina; Díaz-Carrasco, Mª Sacramento (Sociedad Española de Farmacia Hospitalaria, 2021)Objetivo: Realizar un consenso de expertos utilizando el método Delphi para la clasificación del potencial de daño tisular de los antineoplásicos que facilite la toma de decisiones ante una extravasación. Método: El panel ...
-
Fernández-Sala, Xènia; Barceló-Vidal, Jaime; Tusquets, Ignasi; Conde Estévez, David (Sociedad Española de Farmacia Hospitalaria, 2020)Objective: To present a new dexamethasone mouthwash formulation and analyze its effectiveness and safety among patients receiving stomatitis-producing antineoplastic agents. Method: Prospective observational study conducted ...
-
Florit-Sureda, Marta; Conde Estévez, David; Vidal Barrull, Joana; Montagut Viladot, Clara (Maney Publishing, 2016)5-Fluorouracil (5-FU) is combined with folinic acid (FA) for enhancing its cytotoxic effects in the colon cancer chemotherapy treatment. Folinic acid has rarely been involved in hypersensitivity reactions. Here, we report ...
-
Barrantes-González, Melisa; Grau Cerrato, Santiago; Conde Estévez, David (Oxford University Press, 2022)Background: Tigecycline is the first member of the glycylcyclines. Both the FDA (2010 and 2013) and the EMA (2011) issued safety warnings describing an increased mortality risk associated with tigecycline compared with ...
-
Echeverría Esnal, Daniel; Martín-Ontiyuelo, Clara; Navarrete Rouco, Maria Eugenia; Barceló-Vidal, Jaime; Conde Estévez, David; Carballo Martínez, Núria; De Antonio Cuscó, Marta; Ferrández, Olivia; Horcajada Gallego, Juan Pablo; Grau Cerrato, Santiago (Taylor & Francis, 2022)Introduction: Aspergillus may cause different types of lung infections: invasive, chronic pulmonary or allergic bronchopulmonary aspergillosis. Pharmacological management with antifungals poses as a challenge. Patients ...
-
Conde Estévez, David; Echeverría Esnal, David; Tusquets Trias de Bes, Ignacio; Albanell Mestres, Joan (Oxford University Press, 2015)
-
Gallardo Hernández, Fernando; Andrades, Evelyn; Iglesias, Arnau; González, Jessica; Solé, Laura; Guillén, Yolanda; Blanco Ares, Gonzalo, 1989-; Colomo Saperas, Luis Alberto; Gimeno, Eva; Conde Estévez, David; Rodríguez, Eva; Bielsa-Marsol, Isabel; Iglesias Coma, Mar; Bellosillo Paricio, Beatriz; Pujol Vallverdú, Ramon Maria; Regueiro, José R.; Bigas Salvans, Anna; Espinosa Blay, Lluís (American Society of Hematology, 2022)Current therapeutic approaches for Sézary syndrome (SS) do not achieve a significant improvement in long-term survival of patients, and they are mainly focused on reducing blood tumor burden to improve quality of life. ...
-
Conde Estévez, David; Barrantes-González, Melisa; Cotrina Soliz, Maria Renne; Grau Cerrato, Santiago (UNLISTED PUBLISHER, 2022)
-
Conde Estévez, David (Springer, 2017)Targeted therapy drugs, mainly those within the signal transduction inhibitors, are used more chronically than cytotoxic drugs and are metabolised by cytochrome P450 isozymes so patients are at high risk of having drug-drug ...
-
Conde Estévez, David; Henríquez¸Iván; Henríquez, Iván; Muñoz-Rodríguez, Jesús; Rodriguez-Vida, Alejo (Informa Healthcare, 2022)Introduction: patients with non-metastatic castration-resistant prostate cancer (nmCRPC) are frequently poly-medicated due to age-related and androgen deprivation therapy (ADT)-derived comorbidities. In high-risk patients, ...
Now showing items 1-11 of 11
© Universitat Pompeu Fabra | Plaça de la Mercè, 10-12. 08002 Barcelona | T. (+34) 93 542 20 00